Physician profile
Amir Lebaschi
NPI 1104027630
$7,966.49
in general payments reported to CMS, 2019-2025
20 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,957 · 2020: $333 · 2021: $823 · 2022: $1,802 · 2023: $804 · 2024: $1,918 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876 · Travel and Lodging: $1,066 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.14 |
| Travel and Lodging | $1,065.81 |
| Education | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,181.68 | 2019-2025 | Oasis, Stravix, Pico |
| Integra Lifesciences Corporation | $1,547.88 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $762.17 | 2019-2024 | |
| Angiodynamics, INC. | $658.98 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $455.91 | 2020-2021 | |
| Acera Surgical, INC. | $249.40 | 2021-2022 | |
| Koelis INC. | $247.80 | 2023-2025 | |
| Inari Medical, INC. | $234.98 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mimedx Group, INC. | $213.07 | 2024 | |
| Melinta Therapeutics, LLC | $204.17 | 2019-2020 | |
| Amgen INC. | $191.72 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $158.45 | 2019 | |
| Organogenesis INC. | $156.97 | 2022-2023 | Puraply |
| In2bones USA, LLC | $145.60 | 2022 | |
| Bioventus LLC | $140.97 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $136.60 | 2019 | |
| Djo, LLC | $109.00 | 2025 | Dr Comfort |
| Cardiovascular Systems INC. | $78.58 | 2021 | |
| Stryker Corporation | $75.42 | 2020-2025 | Ortholoc 3di, Dart-Fire |
| Biotissue Holdings INC. | $17.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Lebaschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.